Walmart and Clorox are among the most overbought stocks on Wall Street. Here are some others

As the S&P 500 nears its all-time high set in mid-July, some stocks may have become too overbought and are due for a pullback. 

The broad market index is on pace to rally for five consecutive positive sessions, and is almost 4% higher this week alone. The tech-heavy Nasdaq Composite has surged 5.8% this week, while the Dow Jones Industrial Average is 2.5% higher. 

That performance has left a host of stocks with outsized gains. With that in mind, CNBC Pro used its stock screener tool to find the most overbought and oversold companies, using each one’s 14-day relative strength index, or RSI. Stocks with a 14-day RSI score above 70 are typically regarded as overbought, indicating a pullback may be looming, while a 14-day RSI under 30 suggests a stock is oversold and may rebound. 

Retail giant Walmart is among this week’s most overbought stocks, with an 14-day RSI reading of 81.7. Although analysts remain bullish on the Arkansas-based chain, the consensus price target is only 1% above the stock’s current level, according to LSEG, indicating a pullback may be ahead. 

Walmart traded at a new all-time high on Friday, bringing the year-to-date gain to a market-beating 53%.

Clorox is another company on the list. The bleach and Glad bag maker has an RSI reading of 78.8 after soaring nearly 25% over the past three months.

Now, analysts are less sure on Clorox, with three-fifths of those covering the company rating it a hold. The average price target on the Oakland, California-based stock is nearly 10% below the stock’s current price, suggesting a pullback may lie ahead. 

Year to date, Clorox shares are up more than 16%. 

Consumer health-care company Kenvue, spun off from Johnson & Johnson in August 2023, was also overbought this week, with an RSI of 78.6. Half the analysts covering the Band-Aid maker rate it a hold, and their average price target implies the stock will decline about 5% over the next year. Shares are up 29% over the past three months.

Let’s take a look at some of this week’s most oversold stocks: 

Several oil companies have suffered even as the broader market has bounced back from sell-offs in August and September. Energy is the only one of the 11 S&P 500 sectors that is down this week, as oil prices closed at a nearly three-year low on Tuesday. 

Oil and oil service stocks Halliburton and APA have 14-day RSI readings of 22.5 and 23.9, respectively. Occidental Petroleum has an RSI reading of 24.4. 

According to consensus price forecasts, these stocks could climb over the next year. Analysts estimate Halliburton and APA might rally nearly 60% each, while Occidental’s price target is 38% above its current level. 

Week to date, Halliburton shares have fallen 3% and APA has declined 5.6%, while Occidental Petroleum has sold off 1.9%. 

Pharmaceutical company Moderna is another unloved name that may soon bounce back. The vaccine maker continued to fall more than 3% on Friday after JPMorgan downgraded it to underweight, citing changes to its revenue forecast. 

The average price target on Moderna implies nearly 76% upside potential for shares, even as most analysts rate the stock a hold. 

Moderna shares have lost 7.4% this week, bringing the 2024 decline to 32%.